| Schedule of Offsetting Assets |
The tables below present a gross presentation, the effects of offsetting, and a net presentation of the Company’s financial instruments that are eligible for offset in the Consolidated Statements of Condition as of March 31, 2026 and December 31, 2025 (in thousands). | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Values of Derivative Instruments as of March 31, 2026 | | | Asset Derivatives | | Liability Derivatives | | | Notional Amount | | Consolidated Statements of Financial Condition | | Fair value (1) | | Notional Amount | | Consolidated Statements of Financial Condition | | Fair value (1) | | Derivatives not designated as a hedging instrument: | | | | | | | | | | | | | | Interest rate products | | $ | 1,944,208 | | | Other assets | | $ | 103,989 | | | 1,944,208 | | | Other liabilities | | 104,217 | | | Credit contracts | | 33,314 | | | Other assets | | 6 | | | 55,003 | | | Other liabilities | | | | Total derivatives not designated as a hedging instrument | | | | | | 103,995 | | | | | | | 104,217 | | | | | | | | | | | | | | | | Derivatives designated as a hedging instrument: | | | | | | | | | | | | | | Interest rate products | | 450,000 | | | Other assets | | 1,262 | | | 225,000 | | | Other liabilities | | 781 | | | | | | | | | | | | | | | | Total gross derivative amounts recognized on the balance sheet | | | | | | 105,257 | | | | | | | 104,998 | | | | | | | | | | | | | | | | Netting Adjustments | | | | | | 1,262 | | | | | | | — | | | Gross amounts offset on the balance sheet | | | | | | — | | | | | | | — | | | Net derivative amounts presented on the balance sheet | | | | | | $ | 103,995 | | | | | | | 104,998 | | | | | | | | | | | | | | | | Gross amounts not offset on the balance sheet: | | | | | | | | | | | | | | Financial instruments - institutional counterparties | | | | | | $ | 4,798 | | | | | | | 4,798 | | | Cash collateral - institutional counterparties | | | | | | 95,081 | | | | | | | — | | | Net derivatives not offset | | | | | | $ | 4,116 | | | | | | | 100,200 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Values of Derivative Instruments as of December 31, 2025 | | | Asset Derivatives | | Liability Derivatives | | | Notional Amount | | Consolidated Statements of Financial Condition | | Fair value (1) | | Notional Amount | | Consolidated Statements of Financial Condition | | Fair value (1) | | Derivatives not designated as a hedging instrument: | | | | | | | | | | | | | | Interest rate products | | $ | 2,000,609 | | | Other assets | | $ | 105,251 | | | $ | 2,000,609 | | | Other liabilities | | 105,453 | | | Credit contracts | | 33,385 | | | Other assets | | 9 | | | 65,167 | | | Other liabilities | | — | | | Total derivatives not designated as a hedging instrument | | | | | | 105,260 | | | | | | | 105,453 | | | | | | | | | | | | | | | | Derivatives designated as a hedging instrument: | | | | | | | | | | | | | | Interest rate products | | — | | | Other assets | | — | | | 575 | | | Other liabilities | | 2,670 | | | | | | | | | | | | | | | | Total gross derivative amounts recognized on the balance sheet | | | | | | 105,260 | | | | | | | 108,123 | | | | | | | | | | | | | | | | Netting Adjustments | | | | | | — | | | | | | | 1,678 | | | Gross amounts offset on the balance sheet | | | | | | — | | | | | | | — | | | Net derivative amounts presented on the balance sheet | | | | | | $ | 105,260 | | | | | | | 106,445 | | | | | | | | | | | | | | | | Gross amounts not offset on the balance sheet: | | | | | | | | | | | | | | Financial instruments - institutional counterparties | | | | | | $ | 7,814 | | | | | | | 7,814 | | | Cash collateral - institutional counterparties | | | | | | 89,000 | | | | | | | — | | | Net derivatives not offset | | | | | | $ | 8,446 | | | | | | | 98,631 | |
(1) The fair values related to interest rate products in the above net derivative tables show the total value of assets and liabilities, which include accrued interest receivable and accrued interest payable for the periods ended March 31, 2026 and December 31, 2025.
|
| Schedule of Offsetting Liabilities |
The tables below present a gross presentation, the effects of offsetting, and a net presentation of the Company’s financial instruments that are eligible for offset in the Consolidated Statements of Condition as of March 31, 2026 and December 31, 2025 (in thousands). | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Values of Derivative Instruments as of March 31, 2026 | | | Asset Derivatives | | Liability Derivatives | | | Notional Amount | | Consolidated Statements of Financial Condition | | Fair value (1) | | Notional Amount | | Consolidated Statements of Financial Condition | | Fair value (1) | | Derivatives not designated as a hedging instrument: | | | | | | | | | | | | | | Interest rate products | | $ | 1,944,208 | | | Other assets | | $ | 103,989 | | | 1,944,208 | | | Other liabilities | | 104,217 | | | Credit contracts | | 33,314 | | | Other assets | | 6 | | | 55,003 | | | Other liabilities | | | | Total derivatives not designated as a hedging instrument | | | | | | 103,995 | | | | | | | 104,217 | | | | | | | | | | | | | | | | Derivatives designated as a hedging instrument: | | | | | | | | | | | | | | Interest rate products | | 450,000 | | | Other assets | | 1,262 | | | 225,000 | | | Other liabilities | | 781 | | | | | | | | | | | | | | | | Total gross derivative amounts recognized on the balance sheet | | | | | | 105,257 | | | | | | | 104,998 | | | | | | | | | | | | | | | | Netting Adjustments | | | | | | 1,262 | | | | | | | — | | | Gross amounts offset on the balance sheet | | | | | | — | | | | | | | — | | | Net derivative amounts presented on the balance sheet | | | | | | $ | 103,995 | | | | | | | 104,998 | | | | | | | | | | | | | | | | Gross amounts not offset on the balance sheet: | | | | | | | | | | | | | | Financial instruments - institutional counterparties | | | | | | $ | 4,798 | | | | | | | 4,798 | | | Cash collateral - institutional counterparties | | | | | | 95,081 | | | | | | | — | | | Net derivatives not offset | | | | | | $ | 4,116 | | | | | | | 100,200 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Values of Derivative Instruments as of December 31, 2025 | | | Asset Derivatives | | Liability Derivatives | | | Notional Amount | | Consolidated Statements of Financial Condition | | Fair value (1) | | Notional Amount | | Consolidated Statements of Financial Condition | | Fair value (1) | | Derivatives not designated as a hedging instrument: | | | | | | | | | | | | | | Interest rate products | | $ | 2,000,609 | | | Other assets | | $ | 105,251 | | | $ | 2,000,609 | | | Other liabilities | | 105,453 | | | Credit contracts | | 33,385 | | | Other assets | | 9 | | | 65,167 | | | Other liabilities | | — | | | Total derivatives not designated as a hedging instrument | | | | | | 105,260 | | | | | | | 105,453 | | | | | | | | | | | | | | | | Derivatives designated as a hedging instrument: | | | | | | | | | | | | | | Interest rate products | | — | | | Other assets | | — | | | 575 | | | Other liabilities | | 2,670 | | | | | | | | | | | | | | | | Total gross derivative amounts recognized on the balance sheet | | | | | | 105,260 | | | | | | | 108,123 | | | | | | | | | | | | | | | | Netting Adjustments | | | | | | — | | | | | | | 1,678 | | | Gross amounts offset on the balance sheet | | | | | | — | | | | | | | — | | | Net derivative amounts presented on the balance sheet | | | | | | $ | 105,260 | | | | | | | 106,445 | | | | | | | | | | | | | | | | Gross amounts not offset on the balance sheet: | | | | | | | | | | | | | | Financial instruments - institutional counterparties | | | | | | $ | 7,814 | | | | | | | 7,814 | | | Cash collateral - institutional counterparties | | | | | | 89,000 | | | | | | | — | | | Net derivatives not offset | | | | | | $ | 8,446 | | | | | | | 98,631 | |
(1) The fair values related to interest rate products in the above net derivative tables show the total value of assets and liabilities, which include accrued interest receivable and accrued interest payable for the periods ended March 31, 2026 and December 31, 2025.
|
| Schedule of Effect of the derivative financial instruments on the Income Statement |
The tables below present the effect of the Company’s derivative financial instruments on the Consolidated Statements of Income during the three months ended March 31, 2026 and 2025 (in thousands). | | | | | | | | | | | | | | | | | | | | | | | | | Gain (loss) recognized in income on derivatives for the three months ended | | | Consolidated Statements of Income | | March 31, 2026 | | March 31, 2025 | | Derivatives not designated as a hedging instrument: | | | | | | | | Interest rate products | | Other income | | $ | (22) | | | (86) | | | Credit contracts | | Other income | | (3) | | | (1) | | | Total derivatives not designated as hedging instruments | | | | $ | (25) | | | (87) | | | | | | | | | | Derivatives designated as a hedging instrument: | | | | | | | | Interest rate products | | Interest expense | | $ | (93) | | | (1,940) | | | Total derivatives designated as a hedging instruments | | | | $ | (93) | | | (1,940) | |
|